mylife system and Dexcom's CGM

Ypsomed partners with Dexcom

mylife Stories

We have recently entered a partnership with Dexcom to improve your diabetes therapy system. This partnership will make it possible for you to use the Dexcom G6 CGM system as part of the mylife Diabetescare therapy system. Thanks to this integration, you will be able to review mylife YpsoPump insulin data as well as Dexcom’s continuous glucose monitoring data in your mylife App on your smartphone.

Burgdorf/San Diego – Ypsomed (SWX:YPSN) and DexCom Inc. (NASDAQ:DXCM), the world's leading provider of continuous glucose monitoring (CGM) systems, announce their partnership to drive development of a hybrid closed loop system. The partnership is an important milestone in the further development of individualised diabetes therapy. In a first step, CGM data from Dexcom will be integrated into the mylife App from Ypsomed.

Ypsomed Diabetes Care supply situation

mylife Stories

We would like to update our customers very open and transparent on the supply situation related to the Corona virus (Sars-CoV-2).

Topics:

A mother with a child eating cake

Always keep hypo treats close at hand

mylife Stories

People with diabetes who are treated with antidiabetics or insulin are at risk of too low blood glucose levels. These hypoglycaemia can have serious consequences. If you take medication for diabetes, it is therefore of crucial importance to always take fast-acting sugar, so-called hypo treats, with you and have them ready to hand at all times.